Gunnar Kahlmeter
#149,437
Most Influential Person Now
Gunnar Kahlmeter's AcademicInfluence.com Rankings
Gunnar Kahlmeterphilosophy Degrees
Philosophy
#8199
World Rank
#11534
Historical Rank
Logic
#5229
World Rank
#6612
Historical Rank

Gunnar Kahlmeterbiology Degrees
Biology
#11070
World Rank
#14445
Historical Rank
Microbiology
#621
World Rank
#689
Historical Rank

Download Badge
Philosophy Biology
Why Is Gunnar Kahlmeter Influential?
(Suggest an Edit or Addition)Gunnar Kahlmeter's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (2012) (8638)
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) (2610)
- The global threat of antimicrobial resistance: science for intervention (2015) (834)
- An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. (2003) (686)
- ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. (2014) (646)
- EUCAST expert rules in antimicrobial susceptibility testing. (2013) (548)
- Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories. (2014) (543)
- European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria. (2003) (361)
- European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. (2006) (355)
- The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee. (2017) (346)
- Aminoglycoside toxicity - a review of clinical studies published between 1975 and 1982. (1984) (337)
- Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values. (2006) (329)
- Antimicrobial susceptibilities of Lactobacillus, Pediococcus and Lactococcus human isolates and cultures intended for probiotic or nutritional use. (2007) (320)
- Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. (2012) (241)
- The role of pharmacokinetics/pharmacodynamics in setting clinical MIC breakpoints: the EUCAST approach. (2012) (229)
- Biological Costs and Mechanisms of Fosfomycin Resistance in Escherichia coli (2003) (223)
- Dissemination of Escherichia coli with CTX-M Type ESBL between Humans and Yellow-Legged Gulls in the South of France (2009) (217)
- MIC-based dose adjustment: facts and fables (2018) (207)
- Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. (2017) (200)
- Dissemination of Multidrug-Resistant Bacteria into the Arctic (2008) (192)
- New Method for the Serological Grouping of Streptococci with Specific Antibodies Adsorbed to Protein A-Containing Staphylococci (1973) (191)
- Biosafety assessment of probiotics used for human consumption: recommendations from the EU-PROSAFE project (2008) (179)
- CHAPTER 9 – Laboratory control of antimicrobial therapy (2010) (175)
- Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. (2011) (175)
- Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe (2016) (173)
- Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. (2003) (168)
- Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. (2010) (168)
- The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. (2006) (163)
- Developmental roadmap for antimicrobial susceptibility testing systems (2018) (162)
- Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. (2008) (156)
- Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. (2003) (151)
- Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial (2012) (149)
- European recommendations for antimicrobial resistance surveillance. (2004) (149)
- Redefining extended-spectrum beta-lactamases: balancing science and clinical need. (2008) (143)
- Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria (2015) (135)
- Genetic Basis of Resistance to Fusidic Acid in Staphylococci (2007) (116)
- Challenging a dogma: antimicrobial susceptibility testing breakpoints for Mycobacterium tuberculosis. (2012) (115)
- Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) position statements on polymyxin B and colistin clinical breakpoints. (2020) (104)
- Proposed mechanism for metronidazole resistance in Helicobacter pylori. (1992) (101)
- Staphylococcus lugdunensis in several niches of the normal skin flora. (2010) (100)
- Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis. (2009) (99)
- How to: interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). (2020) (95)
- How to: interpret MICs of antifungal compounds according to the revised clinical breakpoints v. 10.0 European committee on antimicrobial susceptibility testing (EUCAST). (2020) (95)
- The E test for antimicrobial susceptibility testing of Helicobacter pylori. (1993) (94)
- Molecular Characterisation of Trimethoprim Resistance in Escherichia coli and Klebsiella pneumoniae during a Two Year Intervention on Trimethoprim Use (2010) (89)
- Phenotypic Detection of Methicillin Resistance in Staphylococcus aureus by Disk Diffusion Testing and Etest on Mueller-Hinton Agar (2006) (88)
- Reviving old antibiotics. (2015) (85)
- The 2014 Garrod Lecture: EUCAST - are we heading towards international agreement? (2015) (83)
- A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes. (2003) (81)
- Breakpoints for intravenously used cephalosporins in Enterobacteriaceae--EUCAST and CLSI breakpoints. (2008) (79)
- Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections. (2003) (79)
- Antimicrobial Resistance of Escherichia coli Causing Uncomplicated Urinary Tract Infections: A European Update for 2014 and Comparison with 2000 and 2008 (2015) (78)
- EUCAST technical note on tigecycline. (2006) (75)
- Plasmid-mediated quinolone resistance determinants qnr and aac(6')-Ib-cr in Escherichia coli and Klebsiella spp. from Norway and Sweden. (2010) (74)
- Methods for identifying methicillin resistancein Staphylococcus aureus. (2001) (74)
- The EUCAST rapid disc diffusion method for antimicrobial susceptibility testing directly from positive blood culture bottles (2020) (68)
- The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens--interim report. (2000) (68)
- Mannitol Salt Agar-Cefoxitin Combination as a Screening Medium for Methicillin-Resistant Staphylococcus aureus (2005) (67)
- Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. (2003) (66)
- Total hip joint arthroplasty with gentamicin-impregnated cement. A clinical study of gentamicin excretion kinetics. (1983) (66)
- Asymptomatic bacteriuria in a population of elderly in municipal institutional care (2002) (64)
- Clonal Spread Among Swedish Children of a Staphylococcus aureus Strain Resistant to Fusidic Acid (2002) (62)
- Standard and real-time multiplex PCR methods for detection of trimethoprim resistance dfr genes in large collections of bacteria. (2007) (62)
- Association between minimum inhibitory concentration, beta-lactamase genes and mortality for patients treated with piperacillin/tazobactam or meropenem from the MERINO study. (2020) (60)
- Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori. (1994) (60)
- Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data. (2010) (59)
- Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis. (2011) (59)
- Corrigendum to “The global threat of antimicrobial resistance: science for intervention” [New Microbes New Infect 6 (2015): 22–29] (2015) (58)
- Antibiotic stewardship: a call for action by the urologic community. (2013) (58)
- Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species (2009) (57)
- Intrafamilial Spread of Highly Virulent Staphylococcus aureus Strains Carrying the Gene for Panton-Valentine Leukocidin (2002) (57)
- EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories (2020) (56)
- Biofilm Formation by Staphylococcus aureus Isolates from Skin and Soft Tissue Infections (2015) (56)
- Sequence types and plasmid carriage of uropathogenic Escherichia coli devoid of phenotypically detectable resistance. (2012) (52)
- Resistance surveillance studies--comparability of results and quality assurance of methods. (2002) (51)
- Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units (2002) (51)
- Trimethoprim and enterococci in urinary tract infections: new perspectives on an old issue. (2008) (51)
- Defining antibiotic resistance-towards international harmonization (2014) (51)
- Emergence of clonally related multidrug resistant Haemophilus influenzae with penicillin-binding protein 3-mediated resistance to extended-spectrum cephalosporins, Norway, 2006 to 2013. (2014) (50)
- Antimicrobial susceptibility testing of Clostridium difficile using EUCAST epidemiological cut-off values and disk diffusion correlates. (2012) (50)
- Point-Counterpoint: Differences between the European Committee on Antimicrobial Susceptibility Testing and Clinical and Laboratory Standards Institute Recommendations for Reporting Antimicrobial Susceptibility Results (2019) (49)
- Antimicrobial susceptibility to parenteral and oral agents in a largely polyclonal collection of CTX‐M‐14 and CTX‐M‐15‐producing Escherichia coli and Klebsiella pneumoniae (2011) (49)
- Wild-Type MIC Distributions for Aminoglycoside and Cyclic Polypeptide Antibiotics Used for Treatment of Mycobacterium tuberculosis Infections (2010) (49)
- Evaluation of cefoxitin 5 and 10 microg discs for the detection of methicillin resistance in staphylococci. (2005) (48)
- Diversity among 2481 Escherichia coli from women with community-acquired lower urinary tract infections in 17 countries. (2005) (47)
- Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection (1997) (47)
- Harmonization of antimicrobial breakpoints in Europe — Can it be achieved? (2004) (45)
- Evaluation of Four Selective Agars and Two Enrichment Broths in Screening for Methicillin-Resistant Staphylococcus aureus (2008) (44)
- Setting interpretive breakpoints for antimicrobial susceptibility testing using disk diffusion. (2011) (44)
- Antimicrobial susceptibility testing in Sweden. II. Species-related zone diameter breakpoints to avoid interpretive errors and guard against unrecognized evolution of resistance. (1997) (43)
- Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis (2004) (41)
- PROLONGED EXCRETION OF GENTAMICIN IN A PATIENT WITH UNIMPAIRED RENAL FUNCTION (1975) (41)
- Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe. (2015) (39)
- Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. (2011) (39)
- Performance of the EUCAST Disk Diffusion Method, the CLSI Agar Screen Method, and the Vitek 2 Automated Antimicrobial Susceptibility Testing System for Detection of Clinical Isolates of Enterococci with Low- and Medium-Level VanB-Type Vancomycin Resistance: a Multicenter Study (2014) (38)
- How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton. (2020) (37)
- Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica (2015) (37)
- Invasive pneumococcal disease in patients with an underlying pulmonary disorder. (2013) (36)
- Selective reporting of antibiotic susceptibility test results in European countries: an ESCMID cross-sectional survey. (2017) (35)
- Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes. (2008) (34)
- Multiple-compartment pharmacokinetics of tobramycin. (1978) (33)
- Rifampicin-resistant and rifabutin-susceptible Mycobacterium tuberculosis strains: a breakpoint artefact? (2013) (33)
- Redefining extended-spectrum β-lactamases: balancing science and clinical need—authors’ response (2009) (31)
- EUCAST proposes to change the definition and usefulness of the susceptibility category 'Intermediate'. (2017) (29)
- Antimicrobial susceptibility testing of Mycobacterium tuberculosis complex isolates - The EUCAST broth microdilution reference method for MIC determination. (2020) (29)
- The quality of antimicrobial discs from nine manufacturers-EUCAST evaluations in 2014 and 2017. (2019) (28)
- Gentamicin and tobramycin in patients with various infections--nephrotoxicity. (1978) (27)
- High genetic diversity of nitrofurantoin- or mecillinam-resistant Escherichia coli indicates low propensity for clonal spread. (2013) (27)
- Antimicrobial susceptibility testing of Kingella kingae with broth microdilution and disk diffusion using EUCAST recommended media. (2017) (27)
- Norfloxacin treatment of salmonellosis does not shorten the carrier stage. (1990) (26)
- Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Possible use of spiramycin for middle ear infections and for gonococcal and meningococcal nasopharyngeal carriage. (1978) (26)
- Chlorhexidine for prevention of neonatal colonization with group B streptococci. II. Chlorhexidine concentrations and recovery of group B streptococci following vaginal washing in pregnant women. (1983) (26)
- Update from the European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2021) (26)
- Staphylococcus aureus resistant to fusidic acid among Swedish children: A follow-up study (2006) (25)
- Standards for MIC testing that apply to the majority of bacterial pathogens should also be enforced for Mycobacterium tuberculosis complex. (2019) (25)
- Antimicrobial susceptibility testing in Sweden. IV. Quality assurance. (1997) (24)
- Chlorhexidine for prevention of neonatal colonization with group B streptococci. I. In vitro effect of chlorhexidine on group B streptococci. (1983) (23)
- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paper. (2020) (23)
- Chlorhexidine for prevention of neonatal colonization with group B streptococci. III. Effect of vaginal washing with chlorhexidine before rupture of the membranes. (1985) (22)
- Antibiotic Resistance Among Campylobacter jejuni/coli Strains Acquired in Sweden and Abroad: A Longitudinal Study (2003) (22)
- EUCAST evaluation of 21 brands of Mueller-Hinton dehydrated media for disk diffusion testing. (2020) (21)
- Strong correlation between the rates of intrinsically antibiotic-resistant species and the rates of acquired resistance in Gram-negative species causing bacteraemia, EU/EEA, 2016 (2019) (21)
- The need for European professional standards and the challenges facing clinical microbiology (2010) (21)
- Longstanding post-therapeutic gentamicin serum and urine concentrations in patients with unimpaired renal function. A pharmacokinetic evaluation. (1978) (21)
- Determination of chloramphenicol in serum and cerebrospinal fluid with high-pressure liquid chromatography. (1978) (20)
- Antimicrobial susceptibility in Escherichia coli of human and avian origin--a comparison of wild-type distributions. (2009) (19)
- Outbreak of a beta-lactam resistant non-typeable Haemophilus influenzae sequence type 14 associated with severe clinical outcomes (2015) (19)
- Antibiotic Use and Escherichia coli Resistance Trends for Quinolones and Cotrimoxazole in Sweden (2002) (19)
- Coeliac disease and invasive pneumococcal disease: a population-based cohort study (2017) (18)
- Colistin antimicrobial susceptibility testing-can the slow and challenging be replaced by the rapid and convenient? (2017) (18)
- Little difference between minimum inhibitory concentrations of Mycobacterium tuberculosis wild-type organisms determined with BACTEC MGIT 960 and Middlebrook 7H10. (2015) (18)
- Haemophilus influenzae with Non-Beta-Lactamase-Mediated Beta-Lactam Resistance: Easy To Find but Hard To Categorize (2015) (17)
- Epidemiology of fungaemia in Sweden: A nationwide retrospective observational survey (2018) (17)
- Gentamicin and tobramycin in patients with various infections--concentrations in serum and urinary excretion. (1978) (16)
- 'Pre-emptive culturing' will improve the chance of 'getting it right' when empirical therapy of urinary tract infections fails. (2009) (16)
- Applying Pharmacodynamics for Susceptibility Breakpoint Selection and Susceptibility Testing (2007) (16)
- Living with extended-spectrum β-lactamase: a qualitative study of patient experiences. (2013) (16)
- Antibiotics for Ceftriaxone-Resistant Gram-Negative Bacterial Bloodstream Infections. (2019) (16)
- Gentamicin and tobramycin. Clinical pharmacokinetics and nephrotoxicity. Aspects on assay techniques. (1979) (15)
- Vancomycin and netilmicin as first line treatment of peritonitis in CAPD patients. (1985) (15)
- Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB. (2016) (14)
- Netilmicin: clinical pharmacokinetics and aspects on dosage schedules. An overview. (1980) (13)
- Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation. (1980) (13)
- Extended antimicrobial resistance screening of the dominant faecal Escherichia coli and of rare resistant clones. (2005) (13)
- Tetracycline-resistant group A streptococci and pneumococci. (1972) (12)
- Validation of EUCAST zone diameter breakpoints against reference broth microdilution. (2014) (12)
- Staphylococci in primary skin and soft tissue infections in a Swedish county (2008) (11)
- Antimicrobial susceptibility of Corynebacterium diphtheriae and Corynebacterium ulcerans in Germany 2011-17. (2020) (11)
- Staphylococcus aureus bloodstream infections: diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018 (2021) (11)
- Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study (2018) (11)
- Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease (1977) (10)
- Effects of temperature on the detection of methicillin resistance in Staphylococcus aureus using cefoxitin disc diffusion testing with Iso-Sensitest agar. (2009) (9)
- Capsule Typing of Haemophilus influenzae by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (2018) (9)
- Guidelines need controls. (2015) (9)
- MIC-based dose adjustment: facts and fables-authors' response. (2018) (9)
- Effect of excluding duplicate isolates of Escherichia coli and Staphylococcus aureus in a 14 year consecutive database. (2007) (9)
- Burkholderia pseudomallei multi-centre study to establish EUCAST MIC and zone diameter distributions and epidemiological cut-off (ECOFF) values. (2020) (9)
- Commentary: what is the role of the EUCAST reference method for MIC testing of the Mycobacterium tuberculosis complex? (2020) (8)
- Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk (2014) (8)
- Dissemination of Multidrug- Resistant Bacteria (2008) (8)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the outpatient sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (8)
- The proposed Drug Resistance Index (DRI) is not a good measure of antibiotic effectiveness in relation to drug resistance (2019) (8)
- How To: ECOFFs - the why, the how and the don´ts of EUCAST epidemiological cutoff values. (2022) (8)
- Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis. (2020) (8)
- Development of a EUCAST disk diffusion method for the susceptibility testing of rapidly growing anaerobic bacteria using Fastidious Anaerobe Agar (FAA) - Development study using Bacteroides species. (2021) (7)
- Aerococcus urinae and Aerococcus sanguinicola: Susceptibility Testing of 120 Isolates to Six Antimicrobial Agents Using Disk Diffusion (EUCAST), Etest, and Broth Microdilution Techniques (2017) (7)
- Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project (2020) (7)
- Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg (2018) (7)
- Determination of norvancomycin epidemiological cut-off values (ECOFFs) for Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus hominis. (2020) (6)
- Evaluation of spiramycin in meningococcal carriage. (1979) (6)
- Symptomatic bacteriuria in non-catheterized geriatric patients with urinary incontinence; the effect of short-term treatment with pivmecillinam or the combination pivmecillinam-pivampicillin. (1981) (6)
- Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility (2020) (6)
- White Paper: Bridging the gap between surveillance data and antimicrobial stewardship in the animal sector—practical guidance from the JPIAMR ARCH and COMBACTE-MAGNET EPI-Net networks (2020) (6)
- SISOMICIN TREATMENT OF SERIOUS NEONATAL INFECTIONS A Clinical and Pharmacokinetic Study (1977) (6)
- Some causes for variation in aminoglycoside plate assays. (1980) (6)
- Re: In the name of common sense: EUCAST breakpoints and potential pitfalls. National dissemination of EUCAST guidelines is a shared responsibility (2020) (6)
- High frequency of multiresistant respiratory tract pathogens at community level in South India (1999) (5)
- Antimicrobial susceptibility testing – clinical break points and epidemiological cut-off values (2007) (5)
- Within-Population Distribution of Trimethoprim Resistance in Escherichia coli before and after a Community-Wide Intervention on Trimethoprim Use (2014) (5)
- Mecillinam and ampicillin separately or combined in gram-negative septicemia (2005) (5)
- Are breakpoints for phenotypic susceptibility testing no longer needed? (2017) (5)
- [Antibiotic resistance. A real threat in Sweden too]. (1997) (5)
- Detection and Identification of Staphylococcus lugdunensis Are Not Hampered by Use of Defibrinated Horse Blood in Blood Agar Plates (2010) (5)
- Tobramycin in patients with various infections: a clinical evaluation. (1978) (5)
- Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing (2022) (4)
- A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. (2021) (4)
- Disk diffusion antimicrobial-susceptibility testing of the Bacteroides fragilis group using EUCAST clinical minimum inhibitory concentration MIC breakpoints (2013) (4)
- Selective reporting of antibiotic susceptibility testing results: less is more. (2020) (4)
- Fluoroquinolone Resistance in Salmonella and the Utility of Perfloxacin Disk Diffusion (2015) (3)
- New Method for the Serological Grouping of Streptococci with Specific Antib.odies Adsorbed (3)
- Prolonged Excretion of Gentamicin in Patients with Normal Renal Function (1976) (3)
- EUCAST disc diffusion criteria for the detection of mecA-Mediated β-lactam resistance in Staphylococcus pseudintermedius: oxacillin versus cefoxitin. (2019) (3)
- RHEUMATIC AFFECTIONS OF TENDON AND MUSCLE ATTACHMENTS ("TENDINITIS") (1933) (3)
- Performance of the EUCAST disc diffusion method and two MIC methods in detection of Enterobacteriaceae with reduced susceptibility to meropenem: the NordicAST CPE study (2018) (3)
- Swedres | 2010 a Report on Swedish Antibiotic Utilisation and Resistance in Human Medicine 1. Preface 3. Use of Antimicrobials (3)
- Ciprofl oxacin for 7 days versus 14 days in women with acute pyelonephritis : a randomised , open-label and double-blind , placebo-controlled , non-inferiority trial (2012) (3)
- The EUCAST Mueller-Hinton fastidious agar for antimicrobial susceptibility testing of anaerobic bacteria? (2011) (3)
- Comment on: Efficacy of temocillin against MDR Enterobacterales: a retrospective cohort study. (2021) (3)
- Developments in the recent past—hospital hygiene and antimicrobials (2007) (2)
- [A boy suffering from SLT associated hemolytic uremic syndrome]. (1989) (2)
- The roentgen treatment of arthritis (2009) (2)
- Wide variation in activity of antibiotic discs from nine manufacturers. (2016) (2)
- O 0954 Can agar dilution be used for colistin MIC determination ? (2018) (2)
- Employing MIC Data for Mink Pathogens to Propose Tentative Epidemiological Cut-Off Values: A Step Toward Rationalizing Antimicrobial Use in Mink (2020) (2)
- Welcoming countries emerging on the scene of medical sciences in Clinical Microbiology and Infection. (2012) (2)
- Evaluation of 10 brands of pre-poured Mueller-Hinton agar plates for EUCAST disc diffusion testing. (2022) (2)
- Sundqvist, M. et al. Little evidence for reversibility of trimethoprim resistance after a drastic reduction in trimethoprim use. J. Antimicrob. Chemother. 65, 350-360 (2009) (2)
- Update of microbial problems in pediatric otorhinolaryngology: plenary session. (1999) (2)
- O164 A planned dramatic drop in trimethoprim consumption in a 180,000 population did not result in a related decrease in trimethoprim resistance in Escherichia coli (2007) (2)
- Microbiology of acute otitis media and therapeutic consequences. (1995) (2)
- Disc diffusion antimicrobial susceptibility testing of Clostridium difficile (2012) (2)
- SWEDRES - antibiotic consumption and resistance in Sweden, 2008. (2009) (1)
- Authors' CorrigendumEuropean recommendations for antimicrobial resistance surveillance (2004) (1)
- The Brucella blood agar for disk diffusion antimicrobial susceptibility testing of the Bacteroides fragilis group (2011) (1)
- Obituary: Johan Willem Mouton. (2019) (1)
- Scandinavian quality surveys of gentamicin assays 1978-1983. (1985) (1)
- The Brucella blood agar disc diffusion antimicrobial susceptibility testing - reproducibility results for Clostridium difficile ATCC 700057 (2012) (1)
- Modern Physiotherapeutic Measures (1932) (1)
- Developmental roadmap for antimicrobial susceptibility testing systems (2018) (1)
- Aerococcus urinae and Aerococcus sanguinicola (2018) (1)
- I-17 Antimicrobial susceptibility testing through EUCAST (2008) (1)
- Letter: Prolonged excretion of gentamicin in a patient with umimpaired renal function. (1975) (1)
- EUCAST invite comments on new methods for antimicrobial susceptibility testing of anaerobic bacteria. (2021) (1)
- [Perinatal listeriosis--a nosocomial outbreak in an obstetric department]. (1988) (1)
- [Time to abandon "the house wine". Stop for uncritical empiric use of cefuroxime]. (2009) (1)
- P1021 A comparison of antimicrobial susceptibility in non-clinical and clinical isolates of Escherichia coli (2007) (1)
- Antimicrobial Activity and Spectrum of Daptomycin Tested Against Gram-positive Strains Collected in European Hospitals: Results from 7 Years of Surveillance (2003-2009) (2011) (1)
- Jacques F. Acar (1931–2020) (2020) (1)
- Revisiting colistin susceptibility testing: Will adding calcium to Mueller-Hinton agar improve the detection of colistin resistance? (2021) (1)
- NewMethodfortheSerological Grouping of Streptococci withSpecific Antib.odies Adsorbed toProtein A-Containing Staphylococci (1973) (1)
- [Botulism type E--clinical and epidemiological aspects of a new case of poisoning caused by pickled herring]. (1973) (1)
- Pivmecillinam, the paradigm of an antibiotic with low resistance rates in Escherichia coli urine isolates despite high consumption. (2022) (1)
- MICROBIOLOGIA BALKANICA 2011 i h BALKAN CONGRESS OF MICROBIOLOGY 8 th CONGRESS OF SERBIAN MICROBIOLOGISTS (2011) (0)
- First multicentre testing of the EUCAST broth microdilution reference method for MIC determination of Mycobacterium tuberculosis by laboratories of the antimycobacterial susceptibility testing EUCAST subcommittee (AMST (2020) (0)
- P1628 Fluoroquinolone resistance in nalidixic acid-resistant Escherichia coli (2007) (0)
- P877 The impact of a drastic change in selection pressure on trimethoprim resistance genes in clinical Escherichia coli isolates (2007) (0)
- [New guidelines for vancomycin in staphylococcal infections]. (2010) (0)
- Expected phenotypes and Expert Rules are Important Complements to Antimicrobial Susceptibility Testing. (2022) (0)
- P2769 Selection of EUCAST disk potency for WCK 4282 (cefepime-tazobactam, FEP-TAZ) susceptibility testing against Enterobacterales and Pseudomonas aeruginosa (2019) (0)
- P0160 Development of a EUCAST disk diffusion method for rapidly growing anaerobic bacteria using fastidious anaerobe agar (FAA) (2018) (0)
- Antimicrobials: Resistance surveillance Working with the Swedish early warning and antimicrobial resistance surveillance system (2014) (0)
- Performance of a new EUCAST disk diffusion method using fastidious anaerobe agar (FAA) for clinical Bacteroides fragilis group isolates (2018) (0)
- [Urinary tract infections. Treatment with aminoglycosides]. (1979) (0)
- [A new SIR definition for antimicrobial susceptibility testing]. (2019) (0)
- Searching high and low: Call for a joint ESPID-EUCAST survey on dosage of antibacterial agents in children - Part One. (2022) (0)
- ECOFFs for non-tuberculous mycobacteria: towards a EUCAST reference method and clinical breakpoints for antimicrobial susceptibility testing (2020) (0)
- Biofilm Formation by Staphylococcus aureus Isolates from Skin and Soft Tissue Infections (2015) (0)
- The determination of epidemiological cut-off values requires a systematic and joint approach based on quality controlled, non-truncated minimum inhibitory concentration series. (2023) (0)
- polypeptide antibiotics used for the treatment of Mycobacterium tuberculosis 2 (2010) (0)
- Marginal effect on antibiotic resistance following a drastic reduction in trimethoprim use in a community (2009) (0)
- P748 EARSS results:S. pneumoniae resistance related to serogroups? (2007) (0)
- External quality assessment-bringing difficulty, complexity and severity of errors to bear on the assessment of performance in antimicrobial susceptibility testing. (2022) (0)
- O359 Is the ratio of associated Escherichia coli resistance comparable over Europe (2007) (0)
- On NaCl excretion in cases of adiposity (2009) (0)
- Comparison of two disk diffusion-based screening methods for detection and classifi cation of beta-lactam resistance in Haemophilus infl uenzae (2007) (0)
- OP-JANM180274 2738..2747 (2018) (0)
- Inter-Method Susceptibility Comparisons Produced by Several National Methods: Report of Garenoxacin Results Produced by Methods from France, Germany, Spain, Sweden and United Kingdom versus NCCLS (2002) (0)
- Biochemical Phenotyping with the PhenePlate™ System (1993) (0)
- O432 Polyclonal distribution of extended-spectrumβlactamase-producing Escherichia coli and Klebsiella pneumoniae in Stockholm (2007) (0)
- The Relation between the State, the Health Resort and National Health Insurance. V. Sweden. (0)
- Development of EUCAST zone diameter breakpoints and quality control range for Staphylococcus aureus with ceftaroline 5-μg disk (2014) (0)
- Reply from Kahlmeter and Giske to Brecher, ‘EUCAST and CLSI Point-Counterpoint on Susceptibility Breakpoints: Do Two “I Agree”s Miss the Point?’ (2019) (0)
- Towards clinical breakpoints for non-tuberculous mycobacteria - Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution. (2023) (0)
- Adaptation of Brucella melitensis Antimicrobial Susceptibility Testing to the ISO 20776 Standard and Validation of the Method (2022) (0)
- Linking local microbiology databases with the Swedish Intensive Care Registry to examine impact of bacterial resistance on the critically ill. (2007) (0)
- Antibiotic Susceptibility of Kingella kingae (2016) (0)
- P1606 In vitro evaluation of MRSA screening methods (2007) (0)
- [The Swedish penicillin V model]. (2001) (0)
- Searching High and Low: Call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on Dosage of Antibacterial Agents in Children-Part One. (2022) (0)
- Escherichia coli before and after a community wide intervention on (2014) (0)
- Wide consultation on fluoroquinolone MIC breakpoints for Enterococcus spp. from urinary tract infections (2014) (0)
- The EUCAST disk diffusion susceptibility testing method for frequently isolated anaerobic bacteria. (2023) (0)
- [Registration of postoperative wound infections. A tool for self scrutiny]. (1989) (0)
- Antibiotic-containing Bioceramics Can Provide Safe and Effective Treatment in Bone and Joint Infections (2012) (0)
- O362 Pseudomonas aeruginosa resistance rates in association with level of hospital care: data from the EARSS (2007) (0)
- Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis. (2004) (0)
- Is there such a Condition as Allergic Arthritis (1939) (0)
- Development of EUCAST zone diameter breakpoints and quality control criteria for ceftazidime-avibactam 10-4 μg (2018) (0)
- Clinical Value of a Routine Urine Culture Prior to Transrectal Prostate Biopsy (2022) (0)
- Patho‐Anatomical Investigations of Cases of Encephalomyelitis Disseminata Acuta (»Neuraxitis Focalis Acuta») Probably Belonging to Morbus Economo (2009) (0)
- [Chlamydia self testing in the county of Kronoberg--an alternative to "Internet Chlamydia tests"]. (2010) (0)
- Report from the EUCAST Subcommittee on the Role of Whole Genome Sequencing ( WGS ) in Antimicrobial Susceptibility Testing of Bacteria . Version 1 , 2016 (2016) (0)
- Scandinavian Quality Surveys of Gentamicin Assays 1978–1983 (1985) (0)
- Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) for Capsule Typing of Haemophilus influenzae (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gunnar Kahlmeter?
Gunnar Kahlmeter is affiliated with the following schools: